Randomized, double‐blind, phase III study to evaluate the efficacy and safety of once‐daily treatment with alogliptin and metformin hydrochloride in Japanese patients with type 2 d...

por Kaku, Kohei, Sumino, Shuuji, Katou, Masafumi, Nishiyama, Yuya, Kinugawa, Yoshinobu
Publicado 2017